Logo image
PD Dr. med. Isabel Rauscher working place, University Hospital Rechts der Isar Munich
PD Dr. med. Isabel Rauscher
Excellent
AiroScore
9.70

PD Dr. med. Isabel Rauscher

nuclear medicine, PSMA ligand
nuclear medicine, PSMA ligand
User ScoreExperienceRatingPrice RangePublicationsOnline Consultations
96%15 years9.7/10$$$$87No

Overview

Country, City
Germany, Munich
Health facility
University Hospital Rechts der Isar Munich
Medical unit
Department of nuclear medicine, molecular and radionuclide therapy

About the doctor

Dr. Isabel Rauscher is a highly accomplished nuclear medicine specialist with an impressive career spanning over many years. With a background in diagnostic radiology and a focus on cancer research, she has won several prestigious awards for her outstanding scientific achievements. Dr. Rauscher's expertise lies in the use of advanced imaging techniques, such as PET/MR and PET/CT, to diagnose and treat various types of cancer. Her research on prostate cancer, particularly related to PSMA ligand PET imaging, has significantly contributed to improving patient outcomes and guiding personalized treatment plans. With scientific publications to her name, Dr. Rauscher is undoubtedly a leading authority in the field of nuclear medicine. Working at Klinikum rechts der Isar, TU Munich, Dr. Rauscher has been recognized for her groundbreaking work in cancer imaging and therapy, earning accolades such as the Jörg Mahlstedt Memorial Prize and the Dr. Dagobert Nitz Prize. Her dedication to advancing the field of nuclear medicine, her exceptional research contributions, and her commitment to providing optimal patient care make Dr. Rauscher a highly respected and sought-after professional in her field.

Resume

CV (Curriculum Vitae)

Education
  • 2003-2010 Studied human medicine at the Technical University of Munich and Ludwig Maximilian University of Munich
  • 2007 Research stay as part of my doctorate with Prof. Dr. Thomas Link in the Musculoskeletal and Quantitative Imaging Research Group, Department of Radiology, University of California, San Francisco, USA
  • 2007-2011 Doctorate at the Institute of Diagnostic Radiology at the Technical University of Munich under the supervision of Prof. Dr. Thomas Link, San Francisco, USA: “Meniscal measurements of T1ρ and T2 at MR imaging in healthy subjects and patients with osteoarthritis”, grade: “magna cum laude”
  • 2010 Medical state examination and license to practice medicine
  • 2014-2019 Further training as a specialist in nuclear medicine at the Clinic for Nuclear Medicine, Klinikum rechts der Isar, TU Munich
  • 2019 Habilitation and Venia legendi in Nuclear Medicine, TU Munich
Experience
  • 2010-2011 Assistant physician in the Department of Diagnostic and Interventional Radiology, University Hospital Tübingen
  • 2011-2014 Assistant physician at the Institute for Diagnostic and Interventional Radiology, Klinikum rechts der Isar, TU Munich
  • 2020-2021 Assistant physician at the Institute for Diagnostic and Interventional Radiology, Klinikum rechts der Isar, TU Munich
  • 2020 Senior Physician, Department of Nuclear Medicine, Klinikum rechts der Isar, TU Munich
  • 2024 Senior Physician, Department of Nuclear Medicine, Klinikum rechts der Isar, TU Munich
Awards & Memberships
  • 2018 Jörg Mahlstedt Memorial Prize of the Professional Association of German Nuclear Medicine Specialists
  • 2018 Wolfgang Becker Prize of the Bavarian Society for Nuclear Medicine
  • 2019 John Blandy Prize from the British Journal of Urology International
  • 2025 Dr. Dagobert Nitz Prize for outstanding scientific achievement in the field of nuclear medicine, particularly in cancer research

Languages

English flag
English
German flag
German

Publications

Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study.

2 May, 2025

Characterization of Effective Half-Life for Instant Single-Time-Point Dosimetry Using Machine Learning.

1 May, 2025

Prognostic 18F-flotufolastat PET parameters for outcome assessment of 177Lu-labeled PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer.

May, 2025

Location

Ismaninger Str., 22, 81675 Munich, Germany

FAQ

What is the specialization of PD Dr. med. Isabel Rauscher?

The primary specialization of the doctor is nuclear medicine, PSMA ligand.

What is the experience of the specialist?

PD Dr. med. Isabel Rauscher has been practicing for more than 15 years.

What is the rating of the doctor?

Is the specialist involved in the research?

Does the specialist offer online consultations?

No, PD Dr. med. Isabel Rauscher doesn’t perform virtual appointments.

PD Dr. med. Isabel Rauscher
PD Dr. med. Isabel Rauscher

Get individual treatment plan and cost estimate. Non-binding 100% free assessment.

© PD Dr. med. Isabel Rauscher